4 years ago

KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients [Neuroscience]

KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients [Neuroscience]
Michael J. Van Kanegan, Michael A. Schwarzschild, Leslie M. Thompson, Ulrike Trager, Susanta Samaȷdar, Sarah J. Tabrizi, Matthew Fuszard, David Lleres, Luisa Quinti, Lisa Meisel, Kimberly Kegel–Gleason, Linda S. Kaltenbach, Adelaide R. Tousley, Ross Stein, Eranthie Weerapana, Albena T. Dinkova–Kostova, Sebastien Moniot, Clemens Steegborn, James R. C. Miller, Ruth E. Farmer, Lisa M. Ellerby, Sharadha Dayalan Naidu, Lisa A. Crawford, Donald C. Lo, Cho Low, Ningzhe Zhang, Steven M. Hersch, Aleksey G. Kazantsev, Andrew Snyder, Alexei Degterev, Xiqun Chen, Vanita Chopra, Viȷay Potluri, Ellen Sapp, Maureen Higgins, Blair R. Leavitt, Colum Connolly, Petr Vodicka, Marian DiFiglia

The activity of the transcription factor nuclear factor-erythroid 2 p45-derived factor 2 (NRF2) is orchestrated and amplified through enhanced transcription of antioxidant and antiinflammatory target genes. The present study has characterized a triazole-containing inducer of NRF2 and elucidated the mechanism by which this molecule activates NRF2 signaling. In a highly selective manner, the compound covalently modifies a critical stress-sensor cysteine (C151) of the E3 ligase substrate adaptor protein Kelch-like ECH-associated protein 1 (KEAP1), the primary negative regulator of NRF2. We further used this inducer to probe the functional consequences of selective activation of NRF2 signaling in Huntington's disease (HD) mouse and human model systems. Surprisingly, we discovered a muted NRF2 activation response in human HD neural stem cells, which was restored by genetic correction of the disease-causing mutation. In contrast, selective activation of NRF2 signaling potently repressed the release of the proinflammatory cytokine IL-6 in primary mouse HD and WT microglia and astrocytes. Moreover, in primary monocytes from HD patients and healthy subjects, NRF2 induction repressed expression of the proinflammatory cytokines IL-1, IL-6, IL-8, and TNFα. Together, our results demonstrate a multifaceted protective potential of NRF2 signaling in key cell types relevant to HD pathology.

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.